文献速递生殖医学

个性化择期卵母细胞冷冻保存:一种预测多个刺激周期中卵母细胞获数的全新模型

Personalizing elective oocyte cryopreservation: a novel predictive model for oocyte yield across multiple stimulation cycles.
PubMed 文献 · Hum Reprod · 2025-01-01

本研究基于579例择期卵母细胞冷冻保存患者的回顾性队列数据,构建并比较了5个纳入年龄、AFC、AMH、FSH不同组合的负二项回归模型,用于预测获卵数。包含年龄、AFC、AMH和FSH的模型1在预测良好反应(≥10枚卵母细胞)和足够反应(≥5枚卵母细胞)时AUC最高,分别为0.7922和0.7917。

要点

  • 模型1(年龄+AFC+AMH+FSH)预测良好反应AUC 0.7922,敏感度0.7631,特异度0.694。
  • 模型1预测足够反应AUC 0.7917,敏感度0.7255,特异度0.7481。
  • 模型4(年龄+AMH)在两种反应预测中AUC均最低。

核心结论

  • 纳入年龄、AFC、AMH和FSH的模型1预测准确性最高,可能有助于择期卵母细胞冷冻保存的医患沟通。

研究设计与样本

  • 回顾性队列研究,纳入2016年至2023年在生殖与遗传健康中心(CRGH)接受一个或多个卵巢刺激周期进行择期卵母细胞冷冻保存的患者579例。

主要发现

  • 预测良好反应(≥10枚卵母细胞)时,模型1的AUC为0.7922(95%CI:0.7628-0.8217),模型2为0.7919(95%CI:0.7625-0.8213),模型3为0.7770(95%CI:0.7463-0.8078),模型5为0.7749(95%CI:0.7441-0.8056),模型4为0.7727(95%CI:0.7417-0.8038)。
  • 预测足够反应(≥5枚卵母细胞)时,模型1的AUC为0.7917(95%CI:0.7586-0.8249),模型2为0.7837(95%CI:0.7504-0.8169),模型5为0.7729(95%CI:0.7391-0.8068),模型3为0.7723(95%CI:0.7376-0.8069),模型4为0.7607(95%CI:0.7257-0.7958)。
  • 模型1预测良好反应的敏感度为0.7631(95%CI:0.7190-0.8095),特异度为0.694(95%CI:0.6580-0.7297)。
  • 模型1预测足够反应的敏感度为0.7255(95%CI:0.6940-0.7571),特异度为0.7481(95%CI:0.6890-0.8036)。

关键数值与推荐

  • 卵巢刺激周期后冷冻保存≥10枚卵母细胞定义为良好反应,≥5枚定义为足够反应。

临床怎么用

  • 作者认为,纳入年龄和基线卵巢储备测试的预测模型可能有助于择期卵母细胞冷冻保存女性的医患讨论。
  • 作者提出,在大规模多中心研究中纳入 ethnicity 和既往EOC结局作为模型变量可能提高模型准确性。

局限性

  • 本分析基于单一生育中心的数据,未将患者 ethnicity 或既往获卵数纳入模型变量。
  • 虽然评估了年龄和基线卵巢储备对预测准确性的影响,但模型性能可能在不同患者队列中存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can patient age and ovarian reserve tests predict the number of cryopreserved oocytes in patients undergoing one or more ovarian stimulation cycles for elective oocyte cryopreservation (EOC)? SUMMARY ANSWER: A predictive model incorporating patient age, antral follicle count (AFC), anti-Müllerian hormone (AMH), and FSH levels achieved the greatest predictive accuracy. WHAT IS KNOWN ALREADY: As a consequence of societal evolution, women are increasingly delaying starting a family. However, the natural decline in ovarian reserve and oocyte quality as age advances can increase the risk of age-related fertility decline (ARFD) and involuntary childlessness. EOC is a fertility preservation procedure designed to mitigate against the risk of ARFD. Multiple studies have evaluated the optimum number of cryopreserved oocytes to achieve one or more live births, with many women requiring more than one cycle. Previous studies have modelled oocyte yield in response to ovarian stimulation in single-cycle sub-fertile populations, which limits translatability to a population who are presumed fertile and electively cryopreserving their oocytes. Predictive models incorporating data from multiple cycles in an elective population could aid clinician-patient counselling in women undergoing EOC. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study was conducted using data from patients (N = 579) who underwent one or more ovarian stimulation cycles for EOC at the Centre for Reproductive and Genetic Health (CRGH) between 2016 and 2023 inclusive. Baseline characteristics at each cycle, including age, BMI, AFC, AMH, and FSH levels, were recorded. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Cryopreservation of ≥10 oocytes following an ovarian stimulation cycle was classified as a good response, while ≥5 oocytes indicated an adequate response. The following parameter combinations were subsequently evaluated in negative binomial regression models with generalized estimation equation: (i) age, AFC, AMH, and FSH; (ii) age, AFC, and AMH; (iii) age, AMH, and FSH; (iv) age and AMH; and (v) age and AFC. Receiver operating characteristic curves, with corresponding AUC, sensitivity, and specificity values, were generated for all models. R version 4.4 was used for all statistical analyses. MAIN RESULTS AND THE ROLE OF CHANCE: Model 1 achieved the highest AUC for predicting a good response, AUC: 0.7922 (95% CI: 0.7628-0.8217), with a corresponding sensitivity of 0.7631 (95% CI: 0.7190-0.8095), and a specificity of 0.694 (95% CI: 0.6580-0.7297). Model 2 achieved the second highest AUC of 0.7919 (95% CI: 0.7625-0.8213), followed by Model 3, AUC 0.7770 (95% CI: 0.7463-0.8078). Model 5 achieved an AUC of 0.7749 (95% CI: 0.7441-0.8056), and Model 4 achieved the lowest AUC of 0.7727 (95% CI: 0.7417-0.8038). Similarly, Model 1 achieved the highest AUC for predicting an adequate response, AUC: 0.7917 (95% CI: 0.7586-0.8249), with a corresponding sensitivity of 0.7255 (95% CI: 0.6940-0.7571), and a specificity of 0.7481 (95% CI: 0.6890-0.8036). Model 2 achieved the second highest AUC of 0.7837 (95% CI: 0.7504-0.8169), followed by Model 5, AUC 0.7729 (95% CI: 0.7391-0.8068). Model 3 achieved an AUC of 0.7723 (95% CI: 0.7376-0.8069), and Model 4 similarly achieved the lowest AUC of 0.7607 (95% CI: 0.7257-0.7958). LIMITATIONS, REASONS FOR CAUTION: This analysis, based on data from a single fertility centre, does not incorporate patient ethnicity or previous oocyte yield as model variables. Consequently, while we evaluate the impact of age and baseline ovarian reserve on predictive accuracy, model performance may vary across different patient cohorts. WIDER IMPLICATIONS OF THE FINDINGS: Predictive models incorporating patient age and baseline ovarian reserve tests across multiple cycles may aid clinician-patient discussions for women undergoing EOC. Model accuracy could be enhanced by the incorporation of ethnicity and prior EOC outcomes as model variables in large multicentre studies. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study. None of the authors have any competing interests, nor have they received or are due to receive any payment for writing this article. TRIAL REGISTRATION NUMBER: This cohort study did not require registration. Following consultation with the Medical Advisory Committee at CRGH, ethical approval was not deemed necessary.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Tighe J, Theodorou E, Anson N, et al. Personalizing elective oocyte cryopreservation: a novel predictive model for oocyte yield across multiple stimulation cycles. Hum Reprod. 2025. PMID: 40912270. doi:10.1093/humrep/deaf165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。